Business Description
Immunovia AB
ISIN : SE0006091997
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.06 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -14.95 | |||||
Beneish M-Score | -7.67 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 40.4 | |||||
3-Year EBITDA Growth Rate | -5.3 | |||||
3-Year EPS without NRI Growth Rate | -8.3 | |||||
3-Year FCF Growth Rate | -6 | |||||
3-Year Book Growth Rate | -16 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.58 | |||||
9-Day RSI | 59.32 | |||||
14-Day RSI | 58.23 | |||||
6-1 Month Momentum % | 140.36 | |||||
12-1 Month Momentum % | -71.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.2 | |||||
Quick Ratio | 3.2 | |||||
Cash Ratio | 3.03 | |||||
Days Inventory | 86.67 | |||||
Days Sales Outstanding | 26.06 | |||||
Days Payable | 75.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -123.16 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -295.84 | |||||
Operating Margin % | -16867.43 | |||||
Net Margin % | -17052.08 | |||||
FCF Margin % | -8892.35 | |||||
ROE % | -170.91 | |||||
ROA % | -130.67 | |||||
ROIC % | -207.41 | |||||
ROC (Joel Greenblatt) % | -749.66 | |||||
ROCE % | -146.82 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 33.69 | |||||
PB Ratio | 1 | |||||
Price-to-Tangible-Book | 1.03 | |||||
EV-to-EBIT | -0.04 | |||||
EV-to-Forward-EBIT | -0.22 | |||||
EV-to-EBITDA | -0.07 | |||||
EV-to-Forward-EBITDA | -0.24 | |||||
EV-to-Revenue | 6.6 | |||||
EV-to-Forward-Revenue | 0.61 | |||||
EV-to-FCF | -0.07 | |||||
Price-to-Net-Current-Asset-Value | 1.66 | |||||
Price-to-Net-Cash | 1.85 | |||||
Earnings Yield (Greenblatt) % | -2500 | |||||
FCF Yield % | -183.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Immunovia AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 1.922 | ||
EPS (TTM) (kr) | -9.635 | ||
Beta | 0 | ||
Volatility % | 263.3 | ||
14-Day RSI | 58.23 | ||
14-Day ATR (kr) | 0.277008 | ||
20-Day SMA (kr) | 1.77385 | ||
12-1 Month Momentum % | -71.04 | ||
52-Week Range (kr) | 0.514 - 4.9 | ||
Shares Outstanding (Mil) | 45.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Immunovia AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Immunovia AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Immunovia AB Frequently Asked Questions
What is Immunovia AB(OSTO:IMMNOV)'s stock price today?
When is next earnings date of Immunovia AB(OSTO:IMMNOV)?
Does Immunovia AB(OSTO:IMMNOV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |